Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189927 | SCV000243592 | benign | not specified | 2014-11-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000468785 | SCV000556535 | benign | Tuberous sclerosis 2 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021881 | SCV001183550 | likely benign | Hereditary cancer-predisposing syndrome | 2019-04-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000468785 | SCV002039425 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000468785 | SCV004016208 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003390919 | SCV004129854 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
All of Us Research Program, |
RCV003996868 | SCV004826887 | likely benign | Tuberous sclerosis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537591 | SCV004726084 | likely benign | TSC2-related disorder | 2023-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |